Comments
Loading...
Journey Medical (DERM) Forecast
NewsEarningsJourney Medical (DERM) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestJourney Medical (NASDAQ:DERM) Stock Quotes, Forecast and News Summary
Journey Medical Stock (NASDAQ: DERM) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Journey Medical (DERM) stock?
You can purchase shares of Journey Medical (NASDAQ:DERM) through any online brokerage.
Who are Journey Medical (DERM) competitors?
Other companies in Journey Medical’s space includes: Novo Nordisk (NYSE:NVO), Merck & Co (NYSE:MRK), Verona Pharma (NASDAQ:VRNA), Supernus Pharmaceuticals (NASDAQ:SUPN) and WAVE Life Sciences (NASDAQ:WVE).
What is the forecast, or price target, for Journey Medical (DERM) stock?
Journey Medical has a consensus price target of $8.75.
What is the current price for Journey Medical (DERM)?
The stock price for Journey Medical (NASDAQ: DERM) is $3.905 last updated January 10, 2025 at 12:22 PM EST.
Does Journey Medical (DERM) pay a dividend?
There are no upcoming dividends for Journey Medical.
When is Journey Medical (NASDAQ:DERM) reporting earnings?
Journey Medical’s Q4 earnings are confirmed for Thursday, March 20, 2025.
Is Journey Medical (DERM) going to split?
There is no upcoming split for Journey Medical.
What sector and industry does Journey Medical (DERM) operate in?
Journey Medical is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.